The effect of Neuromyelitis optica (NMO)-IgG and anti-IL-6 receptor monoclonal antibody (SA237; satralizumab) for barrier function at the Blood-Brain Barrier in vitro

MULTIPLE SCLEROSIS JOURNAL(2019)

引用 2|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要